Aakaar Medical Technologies Ltd

Mon 21/09/2026,9:9:34 | NSE : AAKAAR

₹65.000.50 (0.78%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 0.00

Previous Close

₹ 64.50

Volume

0

Mkt Cap ( ₹ Cr)

₹ 92.12

High

₹ 0.00

Low

₹ 0.00

52 Week High

₹ 96.00

52 Week Low

₹ 46.00

Book Value Per Share

₹ 38.49

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Aakaar Medical Technologies Ltd

Your Vote -

Buy

71.43%

Hold

0.00%

Sell

28.57%

71.43%

7 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

57.20

8000

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

8000

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Aakaar Medical Technologies Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    16 Sep 2026, 12:32PM Aakaar Medical Technologies Limited has informed the Exchange about the Outcome of the Meet.
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    8 Sep 2026, 4:09PM Aakaar Medical Technologies Limited has informed the Exchange about Schedule of meet
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    31 Aug 2026, 4:30PM Aakaar Medical Technologies Limited has informed the Exchange about Outcome
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    25 Aug 2026, 12:04PM Aakaar Medical Technologies Limited has informed the Exchange about Schedule of meet
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    20 Aug 2026, 12:52PM Aakaar Medical Technologies Limited has informed the Exchange about the Cancellation Of Investors Meet which was scheduled to be held on 21.08.26
  • Aakaar Medical Tech - General Updates

    24 Jul 2026, 11:11PM Aakaar Medical Technologies Limited has informed the Exchange about General Updates
  • Aakaar Medical Tech - Updates

    24 Jul 2026, 10:52PM Aakaar Medical Technologies Limited has informed the Exchange regarding 'Board Comments on Notice dated 14.07.2026 from National Stock Exchange'.
  • Aakaar Medical Tech - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Jul 2026, 3:02PM Aakaar Medical Technologies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Aakaar Medical Tech - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Jul 2026, 3:13PM Aakaar Medical Technologies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Aakaar Medical Tech - Shareholders meeting

    1 Jul 2026, 6:46PM Aakaar Medical Technologies Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on Jun 30, 2026. Further, the
  • Aakaar Medical Tech - Change in Auditors

    30 Jun 2026, 5:34PM Aakaar Medical Technologies Limited has informed the Exchange regarding Change in Auditors of the company.
  • Aakaar Medical Tech - Amendment to AOA/MOA

    30 Jun 2026, 5:31PM Aakaar Medical Technologies Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
  • Aakaar Medical Tech - Shareholders meeting

    30 Jun 2026, 5:27PM Aakaar Medical Technologies Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on Jun 30, 2026
  • Aakaar Medical Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    22 Jun 2026, 5:16PM Aakaar Medical Technologies Limited has informed the Exchange about Presentation

Key fundamentals

Evaluate the intrinsic value of Aakaar Medical Technologies Ltd stock 

Name March-26 March-25 March-24
Assets 73.0849 45.9411 27.5982
Liabilities 73.0849 45.9411 27.5982
Equity 14.1728 10.4224 0.7
Gross Profit 10.3118 9.7369 4.9989
Net Profit 6.6376 6.0395 2.8702
Cash From Operating Activities -8.3613 -5.4063 -8.0441
NPM(%) 9.91 9.8 6.22
Revenue 66.9641 61.5828 46.111
Expenses 56.6523 51.8459 41.1121
ROE(%) 12.16 11.07 5.26

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Aakaar Medical Technologies Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 831.10 -0.30 21.02 0.00 -26.19 0.60
Lotus Eye Hospital and Institute Ltd 112.65 -2.13 1609.29 0.00 0.39 0.00
Vaishali Pharma Ltd 8.88 1.02 27.75 0.00 15.42 0.00
Astec Lifesciences Ltd 725.55 -0.16 0.00 0.00 -363.14 0.00

Company Info

Our Company was originally incorporated as `Aakaar Medical Technologies Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated June 20, 2013 issued by the Registrar of Companies, Mumbai. Subsequently, our Company was converted into a public limited company pursuant to a resolution passed by our shareholders at an extraordinary general meeting held on July 19, 2024 and a fresh certificate of incorporation dated November 18, 2024 was issued by the Registrar of Companies, Mumbai, recording the change in the name of our Company from `Aakaar Medical Technologies Private Limited' to `Aakaar Medical Technologies Limited'.Major Events:2013- Incorporated as Aakaar Medical Technologies Private Limited.2016- Entered into licensing, marketing and distribution agreement with Medytox Inc., South Korea for launch of Siax.2017- Launched our own brands Tubelite.- Launched our own brand Balback.- Launched our own brand Lytec.2018-Entered into a tripartite agreement with ACPL and Croma Pharma GmbH for launch of Saypha filler (earlier known as Princess).2022- Launched our own brand Etrelume.2023- Launched our own brand Swyada.- Entered into exclusive agreement in licensing, marketing and distribution with Regenera Activa Worldwide S.L for launch of Regenera ActivaAMT.- Entered into exclusive agreement in licensing, marketing and distribution with Tesslift Co. Limited.2024- Launched our own brand Exoluxe and DRS1512.- Launched our Own brand Eoluxe.- Conversion of our Company from a private limited company to a public limited company.

Our Company was originally incorporated as `Aakaar Medical Technologies Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated June 20, 2013 issued by the Registrar of Companies, Mumbai. Subsequently, our Company was converted into a public limited company pursuant to a resolution passed by our shareholders at an extraordinary general meeting held on July 19, 2024 and a fresh certificate of incorporation dated November 18, 2024 was issued by the Registrar of Companies, Mumbai, recording the change in the name of our Company from `Aakaar Medical Technologies Private Limited' to `Aakaar Medical Technologies Limited'.Major Events:2013- Incorporated as Aakaar Medical Technologies Private Limited.2016- Entered into licensing, marketing and distribution agreement with Medytox Inc., South Korea for launch of Siax.2017- Launched our own brands Tubelite.- Launched our own brand Balback.- Launched our own brand Lytec.2018-Entered into a tripartite agreement with ACPL and Croma Pharma GmbH for launch of Saypha filler (earlier known as Princess).2022- Launched our own brand Etrelume.2023- Launched our own brand Swyada.- Entered into exclusive agreement in licensing, marketing and distribution with Regenera Activa Worldwide S.L for launch of Regenera ActivaAMT.- Entered into exclusive agreement in licensing, marketing and distribution with Tesslift Co. Limited.2024- Launched our own brand Exoluxe and DRS1512.- Launched our Own brand Eoluxe.- Conversion of our Company from a private limited company to a public limited company.

Parent Organisation

Aakaar Medical Technologies Ltd.

Founded

20/06/2013

Managing Director

Mr.Rahul Babasaheb Sawakhande

NSE Symbol

AAKAARSM

FAQ